For the quarter ending 2025-09-30, GBCS had -$107,912 decrease in cash & cash equivalents over the period. $275,795 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Gain on sale of an asset | - | 0 |
| Net loss | 752,365 | -963,996 |
| Depreciation and amortization | - | 725,762 |
| Depreciation | 1,090,461 | - |
| Amortization of deferred loan costs and debt discount | 4,184 | 8,368 |
| Provision for credit losses | 106,763 | 235,956 |
| Accounts receivable | 258,727 | 661,404 |
| Prepaid expenses and other assets | -56,990 | 168,397 |
| Accounts payable and accrued liabilities | -748,246 | 1,375,843 |
| Lease security deposits | 2,000 | 5,900 |
| Other current liabilities | 0 | 400,000 |
| Cash provided by (used) in operating activities | 280,028 | 958,032 |
| Sale of land and building | - | 0 |
| Cash paid for property and equipment | 4,233 | 382,755 |
| Cash (used in) provided by investing activities | -4,233 | -382,755 |
| Proceeds from debt, non-related party | 0 | 50,000 |
| Payments on debt, non-related party | -357,084 | -593,863 |
| Proceeds from line of credit | 200,000 | 13,258 |
| Payment on line of credit | 226,623 | 104,715 |
| Cash used in financing activities | -383,707 | -635,320 |
| Net decrease in cash, cash equivalents and restricted cash | -107,912 | -60,043 |
| Cash and cash equivalents at beginning of period | 1,391,966 | - |
| Cash and cash equivalents at end of period | 1,224,011 | - |
SELECTIS HEALTH, INC. (GBCS)
SELECTIS HEALTH, INC. (GBCS)